pubmed-article:14633675 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14633675 | lifeskim:mentions | umls-concept:C0038975 | lld:lifeskim |
pubmed-article:14633675 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
pubmed-article:14633675 | lifeskim:mentions | umls-concept:C0162326 | lld:lifeskim |
pubmed-article:14633675 | lifeskim:mentions | umls-concept:C0022341 | lld:lifeskim |
pubmed-article:14633675 | pubmed:issue | 22 | lld:pubmed |
pubmed-article:14633675 | pubmed:dateCreated | 2003-11-24 | lld:pubmed |
pubmed-article:14633675 | pubmed:abstractText | Recent studies showed that SV40 is detected in >40% of non-Hodgkin's lymphoma (NHL) in United States, suggesting SV40-contaminated poliovaccines widely used during the period 1955-1963 to be a major source of SV40 in NHL. We examined the presence of SV40 sequences in 122 cases with NHL and 3 with Hodgkin's lymphoma from Japan. The detection rate of SV40 sequences in diffuse large B-cell lymphoma (19%) was higher than that in peripheral blood cells of normal healthy volunteers in Japan (4.7%; P < 0.05) reported previously as controls for comparison with the study results from cancer patients, suggesting a role for SV40 in the development of diffuse large B-cell lymphoma. In contrast, the frequency of SV40 sequences in NHL cases born between 1951 and 1963 (12%), during which SV40-contaminated poliovaccines might have been inoculated, is not significantly different from that in cases born before 1950 (11%) or after 1964 (15%). SV40 is a new candidate etiologic factor for malignant lymphoma not only in the United States but also in Japan. | lld:pubmed |
pubmed-article:14633675 | pubmed:language | eng | lld:pubmed |
pubmed-article:14633675 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14633675 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14633675 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14633675 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14633675 | pubmed:month | Nov | lld:pubmed |
pubmed-article:14633675 | pubmed:issn | 0008-5472 | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:NakatsukaShin... | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:TakakuwaTetsu... | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:AozasaKatsuyu... | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:NomuraShintar... | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:MiyazatoHajim... | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:DongZhimingZ | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:Osaka... | lld:pubmed |
pubmed-article:14633675 | pubmed:author | pubmed-author:LiuAngenA | lld:pubmed |
pubmed-article:14633675 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14633675 | pubmed:day | 15 | lld:pubmed |
pubmed-article:14633675 | pubmed:volume | 63 | lld:pubmed |
pubmed-article:14633675 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14633675 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14633675 | pubmed:pagination | 7606-8 | lld:pubmed |
pubmed-article:14633675 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:meshHeading | pubmed-meshheading:14633675... | lld:pubmed |
pubmed-article:14633675 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14633675 | pubmed:articleTitle | Simian virus 40 sequences in malignant lymphomas in Japan. | lld:pubmed |
pubmed-article:14633675 | pubmed:affiliation | Department of Pathology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. | lld:pubmed |
pubmed-article:14633675 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14633675 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14633675 | lld:pubmed |